📌 Key Takeaways
- Topic: Silica for Rubber: Reinforcement Benefits, Grades and Compounding Tips
- Keywords: silicon nitride
- Published: 2026-11-20 14:00:19
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Calcium Carbonate Filler vs Silica: Performance, Cost and Applications Compared
- What Is the Formula for Silicon Dioxide? SiO₂ Explained
- Wang, Z. & Liu, L. Mesoporous silica supported phosphotungstic acid catalyst for glycerol dehydration to acrolein. Catal. Today 376, 55-64 (2021). Article CAS Google Scholar
- Tosoh Silica: Product Range, Applications and Key Grades
- Beck, J. S. et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc. 114, 10834-10843 (1992). Article CAS Google Scholar
- What Is a Low CTE Filler? Why Fused and Spherical Silica Are Preferred
- Among diverse metal oxide NPs/MSNs nanocomposites, the Fe 3 O 4 NPs with magnetic targeting, magnetic hyperthermia, enzyme-like activity or Fenton reaction activity are the most studied functional nanostructures. Importantly, MSNs can also play a different role in the applications of these nanocomposites. For example, MSNs that confine two different enzymes or enzyme mimics within the pore channel can be used as a nanoreactor for biomimetic cascade catalysis. 178, 179 Gao et al. encapsulated ultrasmall Au and Fe 3 O 4 NPs into the pores of dendritic MSNs for the construction of a tumor microenvironment-responsive nanocatalytic reactor. In the spatially isolated Au-based and Fe 3 O 4 -based reaction chamber, Au NPs exhibited unique glucose oxidase-like activity, catalyzing the conversion of glucose to gluconic acid and H 2 O 2, while the created H 2 O 2 was able to be used by the Fe 3 O 4 -based reaction chamber to boost the production of reactive oxygen species (ROS) by exhibiting peroxidase-like activity. 179 In addition, MSNs are an ideal nanotherapeutic platform that can achieve synergistic treatment of Fe 3 O 4 -mediated catalytic therapy with other therapeutic modalities including PTT, PDT, and chemotherapy, by loading other therapeutic agents. As reported by Li et al., they utilized organo-mesoporous silica to load the ultrasmall Fe 3 O 4 NPs and the photothermal agent Indocyanine Green (ICG). The photothermal effect caused by ICG could promote the Fenton reaction activity of Fe 3 O 4 NPs, thus achieving amplified intracellular oxidative stress. 180 Apart from, Sun et al. reported the construction of core-shelled Fe 3 O 4 @MSNs that encapsulated DOX and 3-amino-1,2,4-triazole (AT). The MSNs-based therapeutic nanoplatform can realize enhanced anti-tumor efficacy by releasing chemotherapeutic drugs for the enhanced catalytic generation of ROS. 181
- How to Buy Fumed Silica: Grade Selection, Sampling and Supplier Evaluation
- Meng, X. et al. Photoluminescence lifetime of black phosphorus nanoparticles and their applications in live cell imaging. ACS Appl. Mater. Interfaces 10, 31136-31145 (2018). Piece CAS PubMed Google Scholar
Silica Market Size 2026: Global Value, Growth Rate and Key Segments
What is silica (SiO₂)?
how to modify nano silica
What is the difference between fumed silica and precipitated silica?
copper clad laminate filler Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61
What drives silica raw material prices?
is silicon dioxide acidic Jung, J.-H. et al. Effect of different sizes of bioactive glass-coated mesoporous silica nanoparticles on dentinal tubule occlusion and mineralization. Clin. Oral. Investig. 23, 2129-2141 (2019). Post PubMed Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.